Seroprevalence of Leptospirosis in Val Müstair, Switzerland

Status Recruiting

Clinical Trial Summary

Human leptospirosis is a zoonotic disease caused by bacteria of the genus Leptospira. Due to its frequent inapparent course or mild severity with unspecific symptoms and limited availability of diagnostic laboratories the incidence of leptospirosis is likely to be underestimated. The hospital of Val Müstair is the major healthcare provider of a rural mountain valley in the canton of Graubünden/ Switzerland with approximately 1500 inhabitants. A relevant prevalence of Leptospira spp. antibodies in the population of the Val Müstair due to its geographic and social risk profile for Leptospira infection, namely the close contact of the population to both livestock and wildlife in agriculture and hunting is estimated. The aim of this study is to analyze the burden of this disease in order to evaluate the need of preventive measures. In addition, seroepidemiological data for the Hepatitis E virus (HEV) and for tularemia will be collected.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05300425
Study type	Observational
Source	University Hospital, Basel, Switzerland
Contact	Michael Osthoff, PD Dr. med.
Phone	+41 61 328 68 28
Email	michael.osthoff@usb.ch
Status	Recruiting
Phase
Start date	March 3, 2022
Completion date	January 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02898519` - Immune Response After Leptospirosis Infection	N/A
Recruiting	`NCT05425524` - Leptospirosis Care Bundle Study	N/A
Completed	`NCT03912506` - Severe Leptospirosis in Non-tropical Areas
Recruiting	`NCT04288674` - Leptospirosis Registry - LeptoScope
Completed	`NCT01080989` - The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands	N/A
Recruiting	`NCT05436756` - Chronic Post-leptospirosis Manifestations in Reunion	N/A
Recruiting	`NCT04882046` - Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia	N/A
Terminated	`NCT00592566` - Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis	Phase 2/Phase 3
Recruiting	`NCT04034550` - Cohort of Hospitalized Patients Suspected of Leptospirosis	N/A
Completed	`NCT05413720` - Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO	N/A
Completed	`NCT01766830` - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)	N/A
Recruiting	`NCT02000635` - Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique
Active, not recruiting	`NCT01607047` - French West Indies Leptospirosis Study
Completed	`NCT03497572` - Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine